Explore AngioDynamics, Inc.'s significant 8-K filing from January 16, 2025. Discover key corporate events and stock information impacting investors.
Explore AngioDynamics' Q2 2024 report highlighting $157.75M in sales, gross margin insights, and strategic restructuring efforts for future growth.
Discover AngioDynamics' latest 8-K filing dated January 8, 2025, highlighting significant events impacting investors. Stay informed on medical device advancements and strategic initiatives.
Discover the latest significant developments from AngioDynamics, Inc. in this 8-K report filed on January 8, 2025. Stay informed about critical events impacting investors.